Attached files

file filename
EX-32.1 - EX-32.1 - BeiGene, Ltd.bgne-20171231ex3215b2684.htm
EX-31.2 - EX-31.2 - BeiGene, Ltd.bgne-20171231ex3129aa8ab.htm
EX-31.1 - EX-31.1 - BeiGene, Ltd.bgne-20171231ex311f959cb.htm
EX-23.1 - EX-23.1 - BeiGene, Ltd.bgne-20171231ex2311b7bb3.htm
10-K - 10-K - BeiGene, Ltd.bgne-20171231x10k.htm

Exhibit 21.1

 

Subsidiaries

 

 

 

 

 

 

 

 

 

Name of Subsidiary

  

Jurisdiction of Incorporation or Organization

Percentage of Ownership by the Registrant

 

 

 

BeiGene (Hong Kong) Co., Limited

 

Hong Kong

100%

 

 

 

 

BeiGene (Beijing) Co., Ltd.

  

People’s Republic of China

100%

 

 

 

 

BeiGene AUS PTY LTD.

  

Australia

100%

 

  

 

 

BeiGene 101

  

Cayman Islands

100%

 

 

 

 

BeiGene (Suzhou) Co., Ltd.

  

People’s Republic of China

100%

 

 

 

 

BeiGene USA, Inc.

  

United States

100%

 

 

 

 

BeiGene Biologics Co., Ltd.

 

People’s Republic of China

95%

 

 

 

 

BeiGene (Shanghai) Co., Ltd.

 

People’s Republic of China

95%

 

 

 

 

BeiGene Guangzhou Biologics Manufacturing Co., Ltd.

 

People’s Republic of China

95%

 

 

 

 

BeiGene (Guangzhou) Co., Ltd.

 

People’s Republic of China

100%

 

 

 

 

BeiGene Pharmaceutical (Shanghai) Co., Ltd.

 

People’s Republic of China

100%

 

 

 

 

BeiGene Switzerland GmbH

 

Switzerland

100%

 

 

 

 

BeiGene Ireland Limited

 

Ireland

100%